A pair of pharma giants have partnered with a prominent cancer research charity in the U.K. on an innovative new approach to testing targeted oncology therapies, building on the country’s national program for tumor testing in a way that may help make it a global center of cancer R&D.

…read more

Source: Pfizer, AstraZeneca back a new strategy for cancer drug R&D


0 No comments